Kings Path Partners’s Johnson & Johnson JNJ Stock Holding History

Kings Path Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279K	Sell	1,099 -86	-7%	-$20K	0.07%	99
2026 Q1	$245K	Hold	1,185	–	–	0.09%	98
2025 Q4	$245K	Hold	1,185	–	–	0.09%	98
2025 Q3	$220K	Hold	1,185	–	–	0.08%	97
2025 Q2	$181K	Hold	1,185	–	–	0.07%	99
2025 Q1	$197K	Sell	1,185 -7,343	-86%	-$1.15M	0.1%	99
2024 Q4	$1.23M	Hold	8,528	–	–	0.53%	40
2024 Q3	$1.38M	Hold	8,528	–	–	0.58%	40
2024 Q2	$1.25M	Buy	+8,528	New	+$1.27M	0.59%	41

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Kings Path Partners's JNJ Position: Q2 2026 in Review

Kings Path Partners reduced its Johnson & Johnson (JNJ) stake by 7.3% in Q2 2026, selling an estimated $20K and leaving 1,099 shares worth $279K. The position accounts for 0.07% of the portfolio, ranked #99.

Kings Path Partners first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.38M in Q3 2024. 1,099 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Kings Path Partners held 1,099 shares of Johnson & Johnson worth $279K as of Q2 2026.
Kings Path Partners sold 86 Johnson & Johnson shares in Q2 2026, an estimated $20K.
Johnson & Johnson made up 0.07% of Kings Path Partners's portfolio in Q2 2026, its #99 holding.
Kings Path Partners first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
Kings Path Partners's Johnson & Johnson position peaked at $1.38M in Q3 2024.
1,099 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.